Annual CFF
$5.39 M
-$89.60 M-94.33%
December 31, 2023
Summary
- As of February 8, 2025, DTIL annual cash flow from financing activities is $5.39 million, with the most recent change of -$89.60 million (-94.33%) on December 31, 2023.
- During the last 3 years, DTIL annual CFF has risen by +$4.06 million (+305.34%).
- DTIL annual CFF is now -96.89% below its all-time high of $173.37 million, reached on December 31, 2019.
Performance
DTIL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.73 M
+$3.03 M+431.77%
September 30, 2024
Summary
- As of February 8, 2025, DTIL quarterly cash flow from financing activities is $3.73 million, with the most recent change of +$3.03 million (+431.77%) on September 30, 2024.
- Over the past year, DTIL quarterly CFF has dropped by -$36.36 million (-90.69%).
- DTIL quarterly CFF is now -97.22% below its all-time high of $134.31 million, reached on June 30, 2019.
Performance
DTIL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$47.36 M
+$3.77 M+8.64%
September 30, 2024
Summary
- As of February 8, 2025, DTIL TTM cash flow from financing activities is $47.36 million, with the most recent change of +$3.77 million (+8.64%) on September 30, 2024.
- Over the past year, DTIL TTM CFF has increased by +$2.62 million (+5.85%).
- DTIL TTM CFF is now -75.38% below its all-time high of $192.33 million, reached on June 30, 2019.
Performance
DTIL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DTIL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.3% | -90.7% | +5.8% |
| 3 y3 years | +305.3% | +403.8% | -49.3% |
| 5 y5 years | -95.0% | +403.8% | -49.3% |
DTIL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.3% | at low | -96.0% | +2173.9% | -59.0% | +1862.6% |
| 5 y | 5-year | -96.9% | +305.3% | -96.0% | +2173.9% | -72.7% | +3463.4% |
| alltime | all time | -96.9% | +674.9% | -97.2% | +334.5% | -75.4% | >+9999.0% |
Precision BioSciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.73 M(+431.8%) | $47.36 M(+8.6%) |
| Jun 2024 | - | $702.00 K(-98.2%) | $43.59 M(-2.6%) |
| Mar 2024 | - | $40.09 M(+1317.8%) | $44.74 M(+730.5%) |
| Dec 2023 | $5.39 M(-94.3%) | $2.83 M(-8417.6%) | $5.39 M(+110.5%) |
| Sep 2023 | - | -$34.00 K(-101.8%) | $2.56 M(+6.1%) |
| Jun 2023 | - | $1.85 M(+149.9%) | $2.41 M(-97.4%) |
| Mar 2023 | - | $741.00 K(>+9900.0%) | $93.48 M(-1.6%) |
| Dec 2022 | $94.98 M(+34.7%) | $0.00(-100.0%) | $94.98 M(-8.1%) |
| Sep 2022 | - | -$180.00 K(-100.2%) | $103.36 M(-10.5%) |
| Jun 2022 | - | $92.92 M(+4031.4%) | $115.46 M(+220.2%) |
| Mar 2022 | - | $2.25 M(-73.2%) | $36.05 M(-48.9%) |
| Dec 2021 | $70.52 M | $8.38 M(-29.7%) | $70.52 M(+13.1%) |
| Sep 2021 | - | $11.92 M(-11.8%) | $62.34 M(+22.3%) |
| Jun 2021 | - | $13.51 M(-63.2%) | $50.96 M(+35.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $36.72 M(>+9900.0%) | $37.73 M(+2739.0%) |
| Dec 2020 | $1.33 M(-99.2%) | $198.00 K(-62.8%) | $1.33 M(-27.7%) |
| Sep 2020 | - | $532.00 K(+86.7%) | $1.84 M(+34.5%) |
| Jun 2020 | - | $285.00 K(-9.2%) | $1.37 M(-99.0%) |
| Mar 2020 | - | $314.00 K(-55.5%) | $135.39 M(-21.9%) |
| Dec 2019 | $173.37 M(+60.9%) | $706.00 K(+1057.4%) | $173.37 M(+1.3%) |
| Sep 2019 | - | $61.00 K(-100.0%) | $171.08 M(-11.1%) |
| Jun 2019 | - | $134.31 M(+250.7%) | $192.33 M(+31.7%) |
| Mar 2019 | - | $38.30 M(-2505.5%) | $146.05 M(+35.5%) |
| Dec 2018 | $107.78 M(<-9900.0%) | -$1.59 M(-107.5%) | $107.78 M(-1.5%) |
| Sep 2018 | - | $21.32 M(-75.8%) | $109.37 M(+24.2%) |
| Jun 2018 | - | $88.03 M(>+9900.0%) | $88.05 M(>+9900.0%) |
| Mar 2018 | - | $20.00 K | $20.00 K |
| Dec 2017 | -$937.00 K | - | - |
FAQ
- What is Precision BioSciences annual cash flow from financing activities?
- What is the all time high annual CFF for Precision BioSciences?
- What is Precision BioSciences annual CFF year-on-year change?
- What is Precision BioSciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Precision BioSciences?
- What is Precision BioSciences quarterly CFF year-on-year change?
- What is Precision BioSciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Precision BioSciences?
- What is Precision BioSciences TTM CFF year-on-year change?
What is Precision BioSciences annual cash flow from financing activities?
The current annual CFF of DTIL is $5.39 M
What is the all time high annual CFF for Precision BioSciences?
Precision BioSciences all-time high annual cash flow from financing activities is $173.37 M
What is Precision BioSciences annual CFF year-on-year change?
Over the past year, DTIL annual cash flow from financing activities has changed by -$89.60 M (-94.33%)
What is Precision BioSciences quarterly cash flow from financing activities?
The current quarterly CFF of DTIL is $3.73 M
What is the all time high quarterly CFF for Precision BioSciences?
Precision BioSciences all-time high quarterly cash flow from financing activities is $134.31 M
What is Precision BioSciences quarterly CFF year-on-year change?
Over the past year, DTIL quarterly cash flow from financing activities has changed by -$36.36 M (-90.69%)
What is Precision BioSciences TTM cash flow from financing activities?
The current TTM CFF of DTIL is $47.36 M
What is the all time high TTM CFF for Precision BioSciences?
Precision BioSciences all-time high TTM cash flow from financing activities is $192.33 M
What is Precision BioSciences TTM CFF year-on-year change?
Over the past year, DTIL TTM cash flow from financing activities has changed by +$2.62 M (+5.85%)